Search Results

(-)-Integerrimine 1 mL  | Purity Not Available

TargetMol

Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.

More Information Supplier Page

(-)-Integerrimine 5 mg  | Purity Not Available

TargetMol

Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.

More Information Supplier Page

(-)-Irofulven 5 mg  | Purity Not Available

TargetMol

Irofulven is an agent of DNA-damaging and antitumor. It is used for the treatment of advanced solid tumors, including prostate, ovarian, and pancreatic cancers.

More Information Supplier Page

(-)-Irofulven 50 mg  | Purity Not Available

TargetMol

Irofulven is an agent of DNA-damaging and antitumor. It is used for the treatment of advanced solid tumors, including prostate, ovarian, and pancreatic cancers.

More Information Supplier Page

(-)-Irofulven 100 mg  | Purity Not Available

TargetMol

Irofulven is an agent of DNA-damaging and antitumor. It is used for the treatment of advanced solid tumors, including prostate, ovarian, and pancreatic cancers.

More Information Supplier Page